Sionna Therapeutics, Inc. · NASDAQ:SION

Enavate Sciences Gp, LLC reported a 5.60% stake in Sionna Therapeutics, Inc. (Schedule 13D)

Event Feb 10, 2025 · Filed Feb 18, 2025

Enavate Sciences Gp, LLC reported a 5.60% stake in Sionna Therapeutics, Inc., 2,478,030 shares, with active intent on Feb 10, 2025. Filed Feb 18, 2025 (Schedule 13D).

Stake
5.60%
Shares
2,478,030
Intent
Active
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Enavate Sciences GP, LLC5.60%2,478,030
Sionna Aggregator, LP5.60%2,478,030

Source

View original at SEC

Related